Skip to main content
All lobbying filings

TODD STRATEGY GROUP

Lobbying for OSRX PHARMACEUTICALS · Ophthalmic treatment.

 Filing 2nd Quarter - Termination
2nd Quarter (Apr 1 - June 30) 2025 · Montana · House · Senate · $50,000.00 income · posted Oct 12, 2025

Official filing document

 Lobbying activity 1
Health Issues

FDA Regulations.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem